These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31293106)

  • 21. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
    Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF
    Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
    Drucker L; Proia RL; Navon R
    Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
    Schneider A; Nakagawa S; Keep R; Dorsainville D; Charrow J; Aleck K; Hoffman J; Minkoff S; Finegold D; Sun W; Spencer A; Lebow J; Zhan J; Apfelroth S; Schreiber-Agus N; Gross S
    Am J Med Genet A; 2009 Nov; 149A(11):2444-7. PubMed ID: 19876898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of deletion-duplication in HEXA gene in five children with Tay-Sachs disease from India.
    Sheth J; Mistri M; Mahadevan L; Mehta S; Solanki D; Kamate M; Sheth F
    BMC Med Genet; 2018 Jul; 19(1):109. PubMed ID: 29973161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.
    Hallam S; Nelson H; Greger V; Perreault-Micale C; Davie J; Faulkner N; Neitzel D; Casey K; Umbarger MA; Chennagiri N; Kramer AC; Porreca GJ; Kennedy CJ
    J Mol Diagn; 2014 Mar; 16(2):180-9. PubMed ID: 24374108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel variants in a large cohort of children with Tay-Sachs disease: An initiative of a multicentric task force on lysosomal storage disorders by Government of India.
    Mistri M; Mehta S; Solanki D; Kamate M; Gupta N; Kabra M; Puri R; Girisha K; Hariharan S; Nampoothiri S; Sheth F; Sheth J
    J Hum Genet; 2019 Oct; 64(10):985-994. PubMed ID: 31388111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
    Colaianni A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.
    Triggs-Raine B; Richard M; Wasel N; Prence EM; Natowicz MR
    Am J Hum Genet; 1995 Apr; 56(4):870-9. PubMed ID: 7717398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tay-Sachs Disease: Two Novel Rare HEXA Mutations from Pakistan and Morocco.
    Bibi F; Ullah A; Bourinaris T; Efthymiou S; Kriouile Y; Sultan T; Haider S; Salpietro V; Houlden H; Kaukab Raja G
    Klin Padiatr; 2021 Sep; 233(5):226-230. PubMed ID: 33831955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.
    Branda KJ; Tomczak J; Natowicz MR
    Genet Test; 2004; 8(2):174-80. PubMed ID: 15345116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
    Prence EM; Natowicz MR; Zalewski I
    Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.
    Bach G; Tomczak J; Risch N; Ekstein J
    Am J Med Genet; 2001 Feb; 99(1):70-5. PubMed ID: 11170098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid identification of HEXA mutations in Tay-Sachs patients.
    Giraud C; Dussau J; Azouguene E; Feillet F; Puech JP; Caillaud C
    Biochem Biophys Res Commun; 2010 Feb; 392(4):599-602. PubMed ID: 20100466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carrier screening in the era of expanding genetic technology.
    Arjunan A; Litwack K; Collins N; Charrow J
    Genet Med; 2016 Dec; 18(12):1214-1217. PubMed ID: 27054707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.